Angiogenesis factor in endometrial carcinoma: a new prognostic indicator?

[1]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[2]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[3]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[4]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[5]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .

[6]  A. Rademaker,et al.  Prognostic Factors Associated With Recurrence in Clinical Stage I Adenocarcinoma of the Endometrium , 1991, Obstetrics and gynecology.

[7]  H. Homesley,et al.  Determinants of Survival of Surgically Staged Patients With Endometrial Carcinoma Histologically Confined to the Uterus: Implications for Therapy , 1992, Obstetrics and gynecology.

[8]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[9]  K. Matsumoto,et al.  Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer. , 1992, American journal of obstetrics and gynecology.

[10]  R. Kurman,et al.  Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus , 1992, Cancer.

[11]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[12]  I. Hart,et al.  Biology of tumour metastasis , 1992, The Lancet.

[13]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[14]  K. Tanaka,et al.  Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. , 1993, Cancer research.

[15]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Folkman.  Angiogenesis and breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Sherer,et al.  Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma , 1995, Obstetrics and gynecology.

[18]  B. Karlan,et al.  HER‐2/neu, p53, and DNA Analyses as Prognosticators for Survival in Endometrial Carcinoma , 1995, Obstetrics and gynecology.